Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Duloxetine claimed for new indication

July 26, 1996

No Comments

Positive safety profile reported on histamine H3 antagonist research

July 26, 1996

No Comments

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

No Comments

RPR describes tachykinin NK1 antagonists

July 26, 1996

No Comments

BMDB shows antinociceptive activity in mouse model

July 26, 1996

No Comments

Trial results described for methylphenidate in head injury patients

July 19, 1996

No Comments

Adenosine A1 antagonists described by German universities

July 19, 1996

No Comments

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

No Comments

Athena Neuroscience's BotB successfully completes phase II in cervical dystonia

July 19, 1996

No Comments

GDNF vital for kidney and enteric nervous system development

July 19, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Duloxetine claimed for new indication

Positive safety profile reported on histamine H3 antagonist research

SEPA-ibuprofen formulation fares well in phase II trial

RPR describes tachykinin NK1 antagonists

BMDB shows antinociceptive activity in mouse model

Trial results described for methylphenidate in head injury patients

Adenosine A1 antagonists described by German universities

Muscarinic cholinergic ligands described by Novo Nordisk

Athena Neuroscience's BotB successfully completes phase II in cervical dystonia

GDNF vital for kidney and enteric nervous system development

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

Neurology/psychiatric RSS

Neurology/psychiatric
RSS